0.765
price up icon5.72%   0.0414
 
loading
Schlusskurs vom Vortag:
$0.7236
Offen:
$0.7447
24-Stunden-Volumen:
216.06K
Relative Volume:
0.89
Marktkapitalisierung:
$10.56M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-6.13%
1M Leistung:
-18.18%
6M Leistung:
-18.62%
1J Leistung:
-98.28%
1-Tages-Spanne:
Value
$0.717
$0.7935
1-Wochen-Bereich:
Value
$0.6507
$0.81
52-Wochen-Spanne:
Value
$0.375
$64.80

AEON Biopharma Inc. Stock (AEON) Company Profile

Name
Firmenname
AEON Biopharma Inc.
Name
Telefon
(949) 354-6499
Name
Adresse
5 Park Plaza, Suite 1750, Irvine
Name
Mitarbeiter
9
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
AEON's Discussions on Twitter

Vergleichen Sie AEON mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AEON
AEON Biopharma Inc.
0.765 9.99M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
444.64 110.88B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
726.21 72.79B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
890.11 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
404.46 54.85B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
189.85 41.41B 447.02M -1.18B -906.14M -6.1812

AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-08-18 Eingeleitet H.C. Wainwright Buy

AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten

pulisher
Dec 08, 2025

Aeon Biopharma Continues Push to Commercialization - Orange County Business Journal

Dec 08, 2025
pulisher
Dec 05, 2025

AEON Biopharma (AEON) Price Target Decreased by 15.28% to 6.22 - Nasdaq

Dec 05, 2025
pulisher
Dec 05, 2025

How AEON Biopharma Inc. Class stock performs in volatility spikesQuarterly Market Review & Fast Gain Stock Trading Tips - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Can AEON Biopharma Inc. Class stock retain market dominanceJuly 2025 Summary & Trade Opportunity Analysis Reports - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

AEON Biopharma Releases New Corporate Presentation - TipRanks

Dec 04, 2025
pulisher
Dec 04, 2025

AEON Biopharma : Corporate Presentation - marketscreener.com

Dec 04, 2025
pulisher
Dec 04, 2025

AEON Biopharma (NYSE: AEON) releases new investor Corporate Presentation - Stock Titan

Dec 04, 2025
pulisher
Dec 04, 2025

AEON Biopharma, Inc. Releases Corporate Presentation on Biosimilar Development - TradingView

Dec 04, 2025
pulisher
Dec 02, 2025

Migraine Clinical Trial Pipeline Expands as 30+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight - GlobeNewswire Inc.

Dec 02, 2025
pulisher
Nov 29, 2025

Aeon Biopharma Reports Positive Data and Strategic Moves - MSN

Nov 29, 2025
pulisher
Nov 28, 2025

Aeon Secures Funding As FDA Sets New Date For Botox Biosimilar Review - Citeline News & Insights

Nov 28, 2025
pulisher
Nov 27, 2025

Check out these key findings about AEON Biopharma Inc (AEON) - Setenews

Nov 27, 2025
pulisher
Nov 21, 2025

How AEON Biopharma Inc. Class stock valuation compares with sector2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

AEON Biopharma (NASDAQ:AEON) Upgraded at Zacks Research - Defense World

Nov 21, 2025
pulisher
Nov 20, 2025

Aeon Biopharma announces first closing of PIPE investment and provides update on FDA Type 2A meeting scheduling - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling - TradingView

Nov 20, 2025
pulisher
Nov 20, 2025

AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling - The Manila Times

Nov 20, 2025
pulisher
Nov 20, 2025

AEON Biopharma Inc: FDA Bpd Type 2a Meeting N - 富途牛牛

Nov 20, 2025
pulisher
Nov 20, 2025

Can AEON Biopharma Inc. Class stock survive global slowdownWeekly Profit Analysis & Expert Curated Trade Setup Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will AEON Biopharma Inc. Class stock beat international competitionWeekly Earnings Recap & Capital Protection Trading Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Applying big data sentiment scoring on AEON Biopharma Inc.July 2025 PostEarnings & Verified Short-Term Plans - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why AEON Biopharma Inc. Class stock signals breakout potentialPortfolio Gains Summary & Smart Allocation Stock Reports - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will AEON Biopharma Inc. Class stock announce special dividendBreakout Watch & Verified High Yield Trade Plans - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will AEON Biopharma Inc. Class stock return to pre crash levelsTrade Risk Report & Free Expert Approved Momentum Trade Ideas - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

What earnings margins imply for AEON Biopharma Inc. Class stockMarket Performance Summary & AI Enhanced Trade Execution Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is AEON Biopharma Inc. Class stock among top earnings plays2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How forex fluctuations impact AEON Biopharma Inc. Class stockJuly 2025 Volume & Weekly Market Pulse Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will AEON Biopharma Inc. price bounce be sustainableJuly 2025 Technicals & Expert Curated Trade Setup Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can AEON Biopharma Inc. stock resist market sell offs - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 04:38:24 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How big funds are accumulating AEON Biopharma Inc. Class stock2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Relative strength of AEON Biopharma Inc. in sector analysisTrade Entry Report & Consistent Profit Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is AEON Biopharma Inc. stock attractive for ETFsQuarterly Profit Summary & Verified Entry Point Signals - newser.com

Nov 19, 2025

Finanzdaten der AEON Biopharma Inc.-Aktie (AEON)

Es liegen keine Finanzdaten für AEON Biopharma Inc. (AEON) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$38.26
price up icon 0.45%
$95.17
price up icon 0.01%
$31.24
price up icon 1.00%
$95.73
price down icon 0.12%
biotechnology ONC
$322.68
price up icon 1.25%
$189.85
price down icon 2.22%
Kapitalisierung:     |  Volumen (24h):